OpenAI acquires Orchestra Bio to automate drug development

PM OS vs Team OS vs Company OS. Here's what each one is, and which to build first: Most people's AI setup still lives on one laptop. It knows their context and their shortcuts, and nobody else on the team gets any of it. Two CPOs I had on the podcast went further. Jiaona Zhang built a harness at Laurel so good that CSMs ship to production. Mikhail Shcheglov made his company's whole system reachable from Telegram. I've now built all three layers. Here's how they differ. 𝟭. 𝗣𝗠 𝗢𝗦 Your own Claude Code setup. It holds your context, your voice and your shortcuts. Only you can see it, and only you get faster. Wade Foster, the CEO of Zapier, rated a PM OS "Adoptive" on his AI fluency scale. Tools: Claude Code. 𝟮. 𝗧𝗲𝗮𝗺 𝗢𝗦 One shared repo your whole team works from. It holds your…

OpenAI just bought this startup to get new drugs to you faster right now it's an agonizingly slow process (takes 10-15 years), and most of those years go into the long slog of studies and trials that's exactly what Orchestra's agents handle. they take over the busywork scientists usually do by hand (checking on studies, chasing deadlines, spotting delays early) and point them to the next step the moment results come in. so now OpenAI has AI for finding the drug AND getting it through the system because back in April OpenAI launched GPT-Rosalind, an AI model for drug discovery Moderna, Amgen and Novo Nordisk already use it feels like they want every big pharma company running their entire drug development process on OpenAI

towards acceleration of drug development, an extremely exciting and promising emerging application of our models